Adaptive thermogenesis in humans

International Journal of Obesity

Volumn 34, Issue , 2010, Pages S47-S55

  Rosenbaum, M ^a   Leibel, R L ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Adaptive thermogenesis; Autonomic; Thyroid; Weight loss

Indexed keywords

LEPTIN;

BODY FAT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CONFERENCE PAPER; ENERGY EXPENDITURE; ERGOMETRY; HUMAN; LEAN BODY WEIGHT; METABOLIC REGULATION; NONHUMAN; PARASYMPATHETIC NERVE; PHENOTYPE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPATHETIC NERVE; THERMOGENESIS; WEIGHT REDUCTION;

ADULT; BODY WEIGHT; DIET; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HUMANS; MALE; OBESITY; THERMOGENESIS; WEIGHT LOSS;

EID: 78449285027     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.184     Document Type: Article

References (99)

1. Leibel R, Chua S, Rosenbaum M. Chapter 157. Obesity. In: Scriver C, Beaudet A, Sly W, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease, Vol. 3, 8th edn. McGraw-Hill: New York, 2001, pp 3965–4028.
2. West DB, Boozer CN, Moody DL, Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992; 262: R1025–R1032.
3. Bouchard C, Tremblay A. Genetic influences on the response of body fat and fat distribution to positive and negative energy balances in human identical twins. J Nutr 1997; 127: 943S–947S.
4. Bouchard C, Tremblay A, Després JP, Nadeau A, Lupien PJ, Theriault G, The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477–1482.
5. Rosenbaum M. Epidemiology of pediatric obesity. Ped Annals 2007; 36: 89–95.
6. Lewis C, Jacobs D, McCreath H, Kiefe C, Schreiner P, Smith D, Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary artery risk development in young adults. Am J Epidemiol 2000; 151: 1172–1181.
7. Moore M. Interactions between physical activity and diet in the regulation of body weight. Proc Nutr Soc 2000; 59: 193–198.
8. McGuire M, Wing R, Klem M, Hill J. Behavioral strategies of individuals who have maintained long-term weight losses. Obes Res 1999; 7: 334–341.
9. Wing R, Hill J. Successful weight loss maintenance. Annu Rev Nutr 2001; 21: 323–341.
10. Klem M, Wing R, Lang W, McGuire M, Hill J. Does weight loss maintenance become easier over time. Obes Res 2000; 8: 438–444.
11. Leibel R, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Eng J Med 1995; 332: 621–628.
12. Weigle D, Sande K, Iverius P, Monsen E, Brunzell J. Weight loss leads to a marked decrease in nonresting energy expenditure in ambulatory human subjects. Metabolism 1988; 37: 930–936.
13. Weyer C, Walford R, Harper I, Milner M, MacCallum T, Tataranni P, Energy metabolism after 2 y of energy restriction: The biosphere 2 experiment. Am J Clin Nutr 2000; 72: 946–953.
14. van Gemert W, Westerterp KR, Acker BA, Wagenmakers AJ, Halliday D, Greve J, Energy, substrate and protein metabolism in morbid obesity before, during and after massive weight loss. Int J Obes 2000; 24: 711–718.
15. Leibel R, Hirsch J. Diminished energy requirements in reducedobese patients. Metabolism 1984; 33: 164–170.
16. dePeuter R, Withers R, Brinkman M, Tomas F, Clark D. No differences in rates of energy expenditure between post-obese women and their matched, lean controls. Int J Obes 1992; 16: 801–808.
17. Amatruda J, Statt M, Welle S. Total and resting energy expenditure in obese women reduced to ideal body weight. J Clin Invest 1993; 92: 1236–1242.
18. Weinsier R, Hunter G, Zuckerman P, Redden D, Darnell B, Larson D, Energy expenditure and free-living physical activity in black and white women: Comparison and after weight loss. Am J Clin Nutr 2000; 71: 1138–1146.
19. Astrup A, Gotzsche P, van de Werken K, Ranneries C, Toubro S, Raben A, Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr 1999; 69: 1117–1122.
20. Rosenbaum M, Vandenborne K, Goldsmith R, Simoneau J, Heymsfield S, Joanisse D, Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol 2003; 285: R183–R192.
21. Klem M, Wing R, McGuire M, Seagle H, Hill J. A descriptive study of individuals successful at long term maintenance of substantial weight loss. Am J Clin Nutr 1998; 66: 239–246.
22. Newcomer B, Larson-Meyer D, Hunter G, Weinsier R. Skeletal muscle metabolism in overweight and post-overweight women: an isometric exercise study using (31)P magnetic resonance spectroscopy. Int J Obes 2001; 25: 1309–1315.
23. Pirke K, Briicjs A, Wilckens T, Marquard R, Schweiger U. Starvation induced hyperactivity in the rat: The role of endocrine and neurotransmitter changes. Neurosci Biobehav Rev 1993; 17: 287–294.
24. Freyschuss U, Melcher A. Exercise energy expenditure in extreme obewsity: Influence of ergometry type and weight loss. Scand J Clin Lab Invest 1978; 38: 753–759.
25. Walter G, Vandenborne K, McCully K, Leigh J. Noninvasive measurement of PCr recovery kinetics in single human muscles. Am J Physiol 1997; 268: C869–C876.
26. Blei M, Conley K, Kushmerick M. Separate measures of ATP utilization and recovery in human skeletal muscle. J Physiol (Lond) 1993; 465: 203–222.
27. Goldsmith R, Joanisse D, Gallagher D, Pavlovich K, Shamoon E, Leibel R, Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. Am J Physiol Regul Integr Comp Physiol 2010; 298: R79–R88.
28. Schwartz M, Woods S, Porte D, Seeley R, Baskin D. Central nervous system control of food intake. Nature 2000; 404: 661–670.
29. Wardlaw S. Clinical review 127: Obesity as a neuroendocrine disease: Lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 2001; 86: 1442–1446.
30. Shimomura Y, Bray GA, Lee M. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice. Horm Metab Res 1987; 19: 295–299.
31. Kennedy S, Brown G, McVrey G, Garfinkel P. Pineal and adrenal function before and after refeeding in anorexia nervosa. Biol Psych 1991; 30: 216–224.
32. Guldstrand M, Ahren B, Wredling R, Backman L, Linus P, Adamson U. Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects. Metabolism 2003; 52: 900–907.
33. Yanovski J, Yanovski S, Gold P, Chorousos G. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. J Clin Endocrinol Metab 1997; 82: 1874–1878.
34. Danforth E, Burger A. The role of thyroid hormones in the control of energy expenditure. Clin Endocrinol Metab 1984; 13: 581–596.
35. al-Adsani H, Hoffer L, Silva J. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 1997; 82: 1118–1125.
36. Rosenbaum M, Hirsch J, Murphy E, Leibel R. The effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am J Clin Nutr 2000; 71: 1421–1432.
37. Goodwin G, Fairburn C, Keenan J, Cowen P. The effects of dieting and weight loss upon the stimulation ofthyrotropin (TSH) bythyrotropin-releasing hormone (TRH) and suppression of cortisol secretion by dexamethasone in men and women. J Affect Dis 1988; 14: 137–144.
38. Guzzaloni G, Grugni G, Moro D, Calo G, Tonelli E, Ardizzi A, Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone in juvenile obesity before and after hypocaloric diet. J Encodrinol Invest 1995; 18: 621–629.
39. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel R. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 1997; 82: 3647–3654.
40. Fekete C, Legradi G, Mihaly E, Huang Q, Tatro J, Rand W, Alpha-melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 2000; 20: 1550–1558.
41. Harris M, Aschkenasi C, Elias C, Chandrankunnel A, Nillni E, Bjorbaek C, Transcriptional regulation of the thyrotropinreleasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001; 107: 111–120.
42. Lang C, Rayos G, Chomsky D, Wood A, Wilson J. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation 1997; 96: 238–245.
43. Aronne L, Mackintosh R, Rosenbaum M, Leibel R, Hirsch J. Autonomic nervous system activity in weight gain and weight loss. Am J Physiol 1995; 38: R222–R225.
44. Kardos A, Taylor D, Thompson C, Styles P, Hands L, Collin J, Sympathetic denervation of the upper limb improves forearm exercise performance and skeletal muscle bioenergetics. Circulation 2000; 13: 2716–2720.
45. Dobbins R, Szczepaniak L, Zhang W, McGarry J. Chemical sympathectomy alters regulation of body weight during prolonged ICV leptin infusion. Am J Physiol 2003; 284: E778–E787.
46. Aronne L, Mackintosh R, Rosenbaum M, Leibel R, Hirsch J. Cardiac autonomic nervous system activity in obese and neverobese young men. Obes Res 1997; 5: 354–359.
47. Kim M, Small C, Stanley S, Morgan D, Seal L, Kong W, The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000; 105: 1005–1011.
48. Flier J, Harris M, Hollenberg A. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest 2000; 105: 859–861.
49. Cannon B, Nedergaard J. Brown adipose tissue: Function and physiological significance. Physiol Rev 2004; 84: 277–359.
50. Trayhurn P, Nicholls D (eds). Brown Adipose Tissue. Edward Arnold: Baltimore, MD, USA, 1986.
51. Leibel R, Berry E, Hirsch J. In vivo evidence for catechol-responsive brown adipose tissue in obese patients. Proceedings of the Fifth International Congress on Obesity, Jerusalem, Israel, 1987.
52. Chemogubova E, Hurchinson D, Nedergaard J, Bengtsson T. Alpha1-and beta1-adrenoceptor signaling fully compensates for beta3-adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake. Endocrinology 2005; 146: 2271–2284.
53. Alkemade A. Central and peripheral effects of thyroid hormone signalling in the control of energy metabolism. J Neuroendocrinol 2010; 22: 56–63.
54. Cypress A, Lehman S, Williams G, Tal I, Rodman D, Goldfine A, Identification and importance of brown adipose tissue in adult humans. N Eng J Med 2009; 360: 1509–1517.
55. Seale P, Lazar M. Brown fat in humans: Turning up the heat on obesity. Diabetes 2009; 68: 1482–1484.
56. Nedergaard J, Connolly E, Cannon B. Brown adipose tissue in the mammalian neonate. In: Trayhurn P, Nicholls D (eds). Brown Adipose Tissue. Edward Arnold: Baltimore, MD, USA, 1986, pp 152–213.
57. Astrup A, Bulow J, Madsen J, Christensen N. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol 1985; 248: E507–E515.
58. Nedergard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol 2007; 293: E444–E452.
59. Truong M, Erasmus J, Munden R, Marom E, Sabloff B, Gladish G, Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET/CT. Am J Roentgenol 2004; 183: 1127–1132.
60. Chib C, Katsuragi I, Simada T, Adachi I, Satoh Y, Noguchi H, Evaluation of human brown adipose tissue using positron emission tomography, computerised tomography and histochemical studies in association with body mass index, visceral fat accumulation and insulin resistance (Abstract). Obes Rev 2006; 7 (2): 87.
61. Jacobsson H, Bruzelius M, Larsson S. Reduction of FDG uptake in brown adipose tissue by propranolol. Eur J Nucl Mol Imaging 2005; 32: 1130.
62. Tatsumi M, Engles J, Ishimori T, Nicely O, Cohade C, Wahl R. Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 2004; 45: 1189–1193.
63. Soderlund V, Larsson S, Jacobsson H. Reduction of FGD uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging 2007; 45: 1018–1022.
64. Lichtenbelt W, Vanjommeng J, Smulders N, Drossaerts J, Kemerink G, Bouvy N, Cold-activated brown adipose tissue in healthy men. N Eng J Med 2009; 360: 1500–1508.
65. Virtanen K, Lidell M, Orava J, Jeglind M, Westergren R, Niemi T, Functional brown adipose tissue in healthy adults. N Eng J Med 2009; 360: 1518–1525.
66. Chernogubova E, Cannon B, Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via 3-adrenoceptors through a cAMP, PKA and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinol 2004; 145: 269–280.
67. Marette A, Bukowiecki L. Noradrenaline stimulates glucose transport in rat brown adipocytes by activating thermogenesis. Evidence that fatty acid activation of mitochondrial respiration enhances glucose transport. Biochem J 1991; 277: 119–124.
68. Elobeid M, Allison D. Putative environmental-endocrine disruptors and obesity: A review. Curr Opin Endocrinol Diabetes Obes 2008; 15: 403–408.
69. Schwartz M, Woods S, Seeley R, Barsh G, Baskin D, Leibel R. Is the energy homeostasis system inherently biased toward weight gain? Diabetes 2003; 52: 232–238.
70. Tremblay A, Després J, Theriault G, Fournier G, Bouchard C. Overfeeding and energy expenditure in humans. Am J Clin Nutr 1992; 56: 857–862.
71. Dulloo A, Girardier L. 24 hour energy expenditure several months after weight loss in the underfed rat: Evidence for a chronic decrease in whole-body metabolic efficiency. Int J Obes 1993; 17: 115–123.
72. Rosenbaum M, Hirsch J, Gallagher D, Leibel R. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr 2008; 88: 906–912.
73. Rothwell N, Stock M. Energy expenditure of cafeteria-fed rats determined from measurements of energy balance and indirect calorimetry. J Physiol (Lond) 1982; 328: 371–377.
74. Levin BE, Triscari J, Sullivan AC. Altered sympathetic activity during development of diet-induced obesity in rat. Am J Physiol 1983; 244: R347–R355.
75. Corbett SW, Stern JS, Keesey RE. Energy expenditure in rats with diet-induced obesity. Am J Clin Nutr 1986; 44: 173–180.
76. Murgatroyd P, Goldberg G, Leahy F, Prentice A. Effects of inactivity and diet composition on human energy balance. Int J Obes 1999; 23: 1269–1275.
77. Doucet E, Cameron J. Appetite control after weight loss: What is the role of bloodborne peptides? Am J Physiol Nutr Metab 2007; 32: 523–532.
78. Kissileff H, Thornton M, Torres M, Pavlovich K, Leibel R, Rosenbaum M. Maintenance of reduced body weight in humans is associated with leptin-reversible declines in satiation (submitted).
79. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield S, Gallagher D, Chu F, Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424–3427.
80. Leibel R. The role of leptin in the control of body weight. Nutr Rev 2002; 60: S15–S19.
81. Heini A, Lara-Castro C, Kirk K, Considine R, Caro J, Weinsier R. Association of leptin and hunger-satiety ratings in obese women. Int J Obes 1998; 22: 1084–1087.
82. Farooqi I, Jebb S, Langmack G, Lawrence E, Cheetham C, Prentice A, Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Eng J Med 1999; 341: 879–884.
83. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546–549.
84. Boozer C, Love R, Cha M, Leibel R, Aronne L. Synergy of leptin and sibutramine in treatment of diet-induced obesity in rats. Metabolism 2001; 50: 889–893.
85. Korner J, Chua S, Williams J, Leibel R, Wardlaw S. Regulation of hypothalamic pro-opiomalanocortin by lean and obese rats. Neuroendocrinol 1999; 70: 377–383.
86. Ollmann M, Wilson B, Yang Y, Kerns J, Chen Y, Barsh G. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135–138.
87. Farooqi I, Keogh J, Yeo G, Lank E, Ceetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Eng J Med 2003; 348: 1085–1095.
88. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency, and red hair pigmentation caused by POMC nutations in humans. Nat Genet 1998; 19: 155–157.
89. Yaswen L, Diehl N, Brennan M, Hochgeswender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999; 5: 1066–1070.
90. Naggert JK, Fricker LD, Varlamov O, Nishin RM, Rouille T, Steiner DF, Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature Genet 1995; 10: 135–142.
91. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson M-L, Sanders L, Montague CT, Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997; 16: 303.
92. Korner J, Wardlaw S, Liu S, Conwell I, Leibel R, Chua S. Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats. Endocrinol 2000; 141: 2465–2471.
93. Solinas G, Summermatter S, Mainieri D, Gubler M, Pirola L, Wymann M, The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation. FEBS Lett 2004; 577: 539–544.
94. Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 1999; 48: 1787–1793.
95. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial. JAMA 1999; 292: 1568–1575.
96. Campfield L, Smith F, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546–548.
97. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Low dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115: 3579–3586.
98. Ravussin E, Smith S, Mitchell J, Shringarpure R, Shan K, Maier H, Enhanced weight loss with pramlintide/metreleptin: An integrated neurohormonal approach to obesity pharmacotherapy. Obesity 2009; 17: 1736–1743.
99. Welt C, Chan J, Bullen J, Murphy R, Smith P, DePaoli A, Recombinant human leptin in women with hypothalamic amenorrhea. N Eng J Med 2004; 351: 987–997.